Literature DB >> 24863847

Microscopic polyangiitis associated with pulmonary fibrosis.

Marcelo Fernandez Casares1, Alejandra Gonzalez, Mariano Fielli, Flavia Caputo, Yanina Bottinelli, Marcelo Zamboni.   

Abstract

Microscopic polyangiitis (MPA) is a systemic necrotizing vasculitis characterised by inflammation of the small blood vessels, the absence of granulommas on histopathological specimens, with few or no immune deposits and the presence of circulating anti-neutrophil cytoplasmic antibodies (ANCAs). The classic pulmonary manifestation is diffuse alveolar haemorrhage (DAH), but its association with pulmonary fibrosis (PF) has been increasingly reported and may be the first manifestation of MPA. Our aim was to evaluate MPA patients with PF and compare their characteristics and evolution to those of MPA patients without PF. We conducted a retrospective review of MPA patients followed in our hospital over a 15-year period. They were divided into two subgroups, with PF (MPA-PF) and without PF (MPA-non PF), and their clinical and functional features were compared. Nine of the 28 patients were classified as MPA-PF (32%). This subgroup showed significantly more respiratory symptoms and higher mortality than MPA-non PF subgroup. The most frequent chest computed tomographic pattern of PF was usual interstitial pneumonia. PF preceded other manifestations of vasculitis in five patients and occurred simultaneously in the remaining four. During the follow-up period, four deaths were reported in the MPA-PF subgroup. No deaths were registered in the MPA-non PF subgroup. We found a high prevalence of MPA-PF patients (32%), most of whom had a poor outcome and PF was often the first manifestation of the disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24863847     DOI: 10.1007/s10067-014-2676-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

Review 1.  Antineutrophil cytoplasmic antibodies (ANCA).

Authors:  A Radice; R A Sinico
Journal:  Autoimmunity       Date:  2005-02       Impact factor: 2.815

Review 2.  ANCA: associated lung fibrosis.

Authors:  Hidehiro Yamada
Journal:  Semin Respir Crit Care Med       Date:  2011-06-14       Impact factor: 3.119

Review 3.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

4.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

5.  Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients.

Authors:  Tomonori Tanaka; Kyoko Otani; Ryoko Egashira; Yukio Kashima; Hiroyuki Taniguchi; Yasuhiro Kondoh; Kensuke Kataoka; Akira Shiraki; Yasuhiko Kitasato; Kevin O Leslie; Junya Fukuoka
Journal:  Respir Med       Date:  2012-09-17       Impact factor: 3.415

6.  A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients.

Authors:  Tomoko Nozu; Mitsuko Kondo; Kazuo Suzuki; Jun Tamaoki; Atsushi Nagai
Journal:  Respiration       Date:  2008-12-11       Impact factor: 3.580

7.  The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.

Authors:  P B Gaudin; F B Askin; R J Falk; J C Jennette
Journal:  Am J Clin Pathol       Date:  1995-07       Impact factor: 2.493

8.  Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides.

Authors:  Sakae Homma; Hiroshi Matsushita; Koichiro Nakata
Journal:  Respirology       Date:  2004-06       Impact factor: 6.424

9.  ANCA-associated lung fibrosis: analysis of 17 patients.

Authors:  Guillaume Foulon; Philippe Delaval; Dominique Valeyre; Benoît Wallaert; Marie-Pierre Debray; Michel Brauner; Pascale Nicaise; Jacques Cadranel; Vincent Cottin; Abdellatif Tazi; Michel Aubier; Bruno Crestani
Journal:  Respir Med       Date:  2008-07-18       Impact factor: 3.415

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  12 in total

1.  Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis.

Authors:  Misbah Baqir; Eunhee E Yi; Thomas V Colby; Christian W Cox; Jay H Ryu; Ulrich Specks
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

3.  Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Gabrielle Y Liu; Iazsmin Bauer Ventura; Natalia Achtar-Zadeh; Brett M Elicker; Kirk D Jones; Paul J Wolters; Harold R Collard; Ayodeji Adegunsoye; Mary E Strek; Brett Ley
Journal:  Chest       Date:  2019-06-07       Impact factor: 9.410

4.  Interstitial lung disease and microscopic polyangiitis in chilean patients.

Authors:  Pamela Wurmann; Francisca Sabugo; Fabian Elgueta; Macarena Mac-Namara; Karen Vergara; Daniela Vargas; Maria Luisa Molina; Juan Carlos Díaz; Hector Gatica; Annelise Goecke
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

5.  Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Adelle S Jee; Robert Sheehy; Peter Hopkins; Tamera J Corte; Christopher Grainge; Lauren K Troy; Karen Symons; Lissa M Spencer; Paul N Reynolds; Sally Chapman; Sally de Boer; Taryn Reddy; Anne E Holland; Daniel C Chambers; Ian N Glaspole; Helen E Jo; Jane F Bleasel; Jeremy P Wrobel; Leona Dowman; Matthew J S Parker; Margaret L Wilsher; Nicole S L Goh; Yuben Moodley; Gregory J Keir
Journal:  Respirology       Date:  2020-11-24       Impact factor: 6.424

Review 6.  Interstitial Lung Disease with ANCA-associated Vasculitis.

Authors:  Yasuhiro Katsumata; Yasushi Kawaguchi; Hisashi Yamanaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-23

7.  Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients.

Authors:  Guillermo Suarez-Cuartin; Maria Molina-Molina
Journal:  Breathe (Sheff)       Date:  2020-03

8.  Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease.

Authors:  Liam M Clifford; Jamma Li; Christopher J Renaud; Suran L Fernando
Journal:  Case Rep Rheumatol       Date:  2019-12-31

Review 9.  MPO-ANCA positive interstitial pneumonia: Current knowledge and future perspectives.

Authors:  Masashi Bando; Sakae Homma; Masayoshi Harigai
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803

Review 10.  Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features.

Authors:  Stefano Palmucci; Corrado Inì; Salvatore Cosentino; Luigi Fanzone; Stefano Di Pietro; Alessia Di Mari; Federica Galioto; Francesco Tiralongo; Giovanna Vignigni; Stefano Toscano; Gianluca Sambataro; Carlo Vancheri; Giulio Distefano; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.